Six-Month Standing Order – Quidel Ortho Reagents
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
|---|---|
| State: | Maryland |
| Type of Government: | Federal |
| FSC Category: |
|
| NAICS Category: |
|
| Posted Date: | Mar 19, 2026 |
| Due Date: | Mar 25, 2026 |
| Solicitation No: | 26-003839 |
| Original Source: | Please Login to View Page |
| Contact information: | Please Login to View Page |
| Bid Documents: | Please Login to View Page |
Description
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
- Contract Opportunity Type: Presolicitation (Original)
- Original Published Date: Mar 19, 2026 09:25 am EDT
- Original Response Date: Mar 25, 2026 09:30 am EDT
- Inactive Policy: Manual
- Original Inactive Date: Mar 26, 2026
-
Initiative:
- None
- Original Set Aside:
- Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
-
NAICS Code:
- 325413 - In-Vitro Diagnostic Substance Manufacturing
-
Place of Performance:
Bethesda , MD 20892USA
This is a notice of intent, NOT a request for a quotation. A solicitation document will NOT be issued, and quotations will NOT be requested.
The National Institutes of Health on behalf of the Department of Transfusion Medicine intends to award a firm-fixed-price purchase order on a sole source basis to:
QuidelOrtho Sales Company, LLC
9975 Summers Ridge Road
San Diego, CA 92121-2997
Decription of Requirement
Six (6) month standing order for QuidelOrtho reagents.
Period of Performance:
April 1, 2026 – September 30, 2026
Supplies
Anti-IgG gel cards (MTS084024)
MTS A/B/D Mono and Reverse gel cards (MTS080515)
Anti-IgG C3d gel cards (MTS084014)
Surgiscreen (6902316)
Affirmagen (719201)
Resolve Panel A (6902317)
MTS Round Diluent 2 (MTS9230)
Alba Q-Chek controls (Z498)
MTS Round Diluent 2+ (MTS9330)
BSA 7% (6844285)
MTS Buffered Gel card (MTS085014)
Justification
QuidelOrtho reagents are the only reagents compatible with the existing Vision analyzer currently used in the department.
No authorized distributors exist. Alternate products would require validation and delay patient care.
Authority
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
Submission
Email capability statements only to:
shasheshe.goolsby@nih.gov
Deadline:
March 25, 2026 at 09:30 AM EST
- 6011 EXECUTIVE BLVD., SUITE 503L
- BETHESDA , MD 20892
- USA
- Shasheshe Goolsby
- shasheshe.goolsby@nih.gov
- Phone Number 3018274879
- Mar 19, 2026 09:25 am EDTPresolicitation (Original)
See Also
Follow Single cell methylation Active Contract Opportunity Notice ID 75N98026Q01085 Related Notice Department/Ind.
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Due by 9/20/2026
Follow Specialized Blood Products-AABB Active Contract Opportunity Notice ID 26-008618 Related Notice Department/Ind.
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Due by 9/20/2026
Follow Electrosurgical unit (ESU) Active Contract Opportunity Notice ID 75F40126Q00277 Related Notice Department/Ind.
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Due by 9/16/2026
Follow NOTICE OF INTENT TO SOLE SOURCE - PROCUREMENT OF THE BIO-RAD CHEMIDOC
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Due by 9/18/2026